Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA

NCT01560754 is registered in ClinicalTrials.gov with James BOYD MD as lead sponsor.

NCT NCT01560754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01560754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA
Lead sponsor
James BOYD MD
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2012
Completion date
December 31, 2016
Enrollment
160 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease